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COMBINED use of X-rays and bleomycin
was initially proposed byJ0rgensen (1972).
The demonstration of synergism attracted
much attention from clinicians as well as
basic researchers. The question arose
whether the effect can be attributed to a
tissue mechanism or to cellular potentia-
tion. In the mean time, several investiga-
tions have been carried out to see whether
the combination is synergistic in bacterial
and mammalian cell systems (Bleehen,
Gillies and Twentyman, 1974; Terasima,
Takabe and Yasukawa, 1975; Bistrovic,
Marici6 and Kolaric, 1976). Although the
experimental results were not consistent
among the cell lines used, the synergism
was found to a slight or moderate extent.
The potentiation presented here, with
Ehrlich ascites tumour cells treated with a
combination ofX-raysandbleomycin, may
involve an interaction of different types of
damage and repair induced by both agents.
Experiments were carried out with
Ehrlich ascites tumour cells grown in
4-week-old male mice 1CR/JCL, weighing
20-25 g (CLEA JAPAN IInc., Tokyo). By
inoculating 106 tumour cells i.p., the early
plateau phase of growth was reached on
the 7th day, when all the experiments were
initiated.
To assay survival of tumour cells, they
were removed from the abdominal cavity
and suspended in F10 medium (Ham, 1963)
with 10% calfserum. The cells were plated
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out in triplicate dishes of soft agar after
they had been counted with electronic
counter (Coulter, Model B) and diluted
appropriately with F1O medium. The agar
colony assay has been described in detail
by Takabe et al. (1977). The plating effi-
ciency (PE) for untreated cells was usually
40-90%. To estimate the surviving frac-
tion, a portion of ascites was removed
from each animal just before the initial
treatment with either agent and the PE of
untreated tumour cells was assayed for
individual mice. Thus, surviving fraction
was expressed as the PE of tumour cells
treated with agent(s) divided by the PE
of untreated cells from the same animal.
Bleomycin complex (Lot No. FlOOS41,
Nippon Kayaku Co., Ltd, Tokyo) was
dissolved in distilled water and diluted in
FIO medium at the time of experiments.
Approximately 0 3 ml ofdrug solution was
injected through an s.c. route in the back
of the mouse. The volume varied slightly
with the body weightofindividualtumour-
bearing mice. All irradiations were given as
whole-body doses to unanaesthetized mice
by X-ray generator (Sinai, Shimazu Rad.
Instr. Co., Ltd, Kyoto) operated at
200 KVp, 20 mA with added filtration
(HVL: 1.2 mm Cu). Tumour-bearing mice
housed in individual spaces of a round,
lucite box were irradiated on a turntable
at the dose rate of 80 rad/min.
Mice bearing tumour cells were either
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treated with a single dose of 0.1 mg/kg
bleomycin or irradiated with a single dose
of 400 rad X-rays. At times indicated in
Fig. IA, ascites fluid was removed repeat-
edly from the abdominal cavity of the
same animal and survival of tumour cells
was assayed. Starting from 1 h after ad-
ministration of bleomycin, the survival
increased quickly with time and finally
levelled off at 5 h (open circles), whereas
the X-ray survival increased rather slowly,
and almost attained a plateau at about 7 h
(closed circles). The survivals, measured as
a ratio of 7-h value to the value of initial
determination (surviving fraction ratio,
after Evans et al., 1974) were 1-7 and 1.5
respectively. Thenumber ofascitestumour
cells was determined following treatment
with either single agent. The result showed
that cells did not resume their prolifera-
tion within the 7-h observation period.
Therefore, the observed enhancement of
survival represents the repair of damage
which was potentially lethal and reparable
only when cells were in the abdominal
cavity (Belli, Dicus and Nagle, 1970; Little
et at., 1973).
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Survivals were also determined with
time after both agents were given simul-
taneously, and are shown in Fig. IA (open
triangles). The surviving fraction ratio was
about 2-5 during the first 7 h, indicating
that repair took place as found after
administration of either single agent. The
survival level was consistently lower
throughout the 7-h period than the level
expected when damage produced by each
agent was independently repaired (broken
line).
A similar experiment was carried out
with single doses of 30 mg/kg bleo-
mycin and of 1000 rad X-rays, as shown in
Fig. 1B. The surviving fraction ratios
given by each agent were much greater
than those in the preceding experiment,
i.e., 441 for bleomycin and 4-2 for X-ray.
In this case, the survivals after simultane-
ous administration of agents (open tri-
angles) were obviouslylower than the level
expected from independent (or additive)
effects of each agent (broken line). This
finding indicates that bleomycin potenti-
ated the effect of X-rays, either by inter-
fering with the repair process of, or by
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FIG. 1.-Change in survival ofEhrlich ascites tumour cells after separate or simultaneous administra-
tion ofbleomycin and X-rays. A: open circles-0-1 mg/kg bleomycin alone; closed circles 400 rad
X-ray alone; triangles-simultaneous administration. B: open circles-30 mg/kg bleomycin alone;
closed circles-1000 rad X-rays alone; triangles-simultaneous administration. Broken line was
given by a product of surviving fractions obtained at various times after the single treatment with
bleomycin (open circles) and X-rays (closed circles). It represents survival level which would be
expected from additive effect of both agents. Survival value with error bar denotes mean ± s.d.
of 4 separate determinations.
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interacting with, damage induced by
X-rays. In the experiment with lower
doses as shown in Fig. IA, the extent of
potentiation was 20-2500 of survival
expected for the additive effect, whereas it
was 50-85% in the case of higher doses
(Fig. 1B). This may imply that the more
the amount of damage, the greater the
potentiation.
Fig. 2 shows the result ofexperiments in
which bleomycin was given to mice at
various times after X-irradiation. A group
of tumour-bearing mice was irradiated
with 400 rad at zero time. Then a single
dose ofbleomycin (0.1 mg/kg) was admini-
stered to each mouse at times indicated.
A tumour-bearing mouse was used for a
single determination. Survival of tumour
cells was determined exactly 1 h after
injection of bleomycin and was plotted at
the time of drug administration (closed
0.9
0.7
0.6
z
° 0.5
4
0r 0.4
0.3 z
0.2
0 1 2 3 4 5 6
TIME AFTER IRRADIATION (h)
7
FIG. 2. Effect ofpost-irradiation exposure to
bleomycin on survival of Ehrlich ascites
tumour cells. Straight arrows incdicate times
when bleomycin (BLAI) was introduced.
Closed symbols: survival for X-rays fol-
lowed by BLM. Bar denotes the range of
determinations. Open symbols: survival for
X-rays alone (from Fig. 1A). Broken line
represents the additive effect obtained as a
product of surviving fraction at various
times after exposure to X-rays alone and
surviving fraction assayed I h after BLAI
(i.e. 0.54 from Fig. IA).
circles). Increase ofsurvival after exposure
to X-rays alone (open circles) is taken
from Fig. IA. If a single dose ofbleomycin
(surviving fraction 0 54 in Fig. IA)
exerted only an independent effect, the ex-
pected survival level would be given as a
product of surviving fraction of both
agents, as shown by the broken line. The
results showed that the survival deter-
mined was clearly lower than the expected
value at zero time, then increased with
time and reached the level of independent
effect after about 3 h.
The next experiments (Fig. 3) were
carried out in a similar fashion to the
preceding ones, except that bleomycin
was injected at various times before X-ray
exposure. A group oftumour-bearing mice
was treated with a single 0-1-mg/kg dose
of bleomycin at zero time. From 1 h on,
each mouse was irradiated with 400 rad at
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FIG. 3. Effect of pre-irradiation exposure to
bleomycin on survival of Ehrlich ascites
tumour cells. Closed symbols: survival for
X-ray with BLM pretreatment. Bar denotes
the range ofdeterminations. Open symbols:
survival for BLM alone (from Fig. IA).
Broken line represents the expected level of
additive effect, obtained as a product of
surviving fraction at various times after
administration of BLM and surviving frac-
tion after 400 rad X-rays (i.e. 0 495 from
Fig. IA).
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specified times. Immediately afterwards,
the ascites fluid was removed and the
surviving fraction oftumour cells assayed.
Therefore, one animal served for a single
determination. Enhancement of survival
after administration of bleomycin alone
(open circles) is as shown in Fig. IA. Ifthe
effect of each agent were independent, the
expected survival would follow the broken
line, which is a product ofsurvivals ofboth
agents. Experimental points were obvi-
ously lower than the broken line over the
first 3 h, and then became close to the level
of independent or additive effect. These
results revealed that (i) more than additive
effect can be obtained only when the inter-
val between two agents was less than 3 h,
whatever the order of administration, and
(ii) the potentiation is greater iftwo agents
are given at closer intervals.
Recently, the induction and repair of
potentially lethal damage was demon-
strated in tumour cells treated with bleo-
mycin (Takabe et al., 1974; Barranco,
Novak and Humphrey, 1975; Twentyman
and Bleehen, 1975). Nevertheless, the
antibiotic does not induce sublethal dam-
age and repair, as the simple exponential
nature of the survival curve suggested
(Terasima et al., 1972; Barranco et al.,
1975).
To effect maximal sterilization of tu-
mour cells treated with an agent inducing
potentially lethal damage, the repair must
be controlled, either by inhibiting enzy-
matic repair reactions or by fixing potenti-
ally lethal damage per 8e. The potentiation
found after the simultaneous administra-
tion of both agents (Fig. 1) suggests that
at least portions of the damage, either
potentially lethal or sublethal, induced by
the two agents interacted each other and
were converted to lethal damage. The
limited period of potentiation found in
Fig. 2 may suggest that the potentiation
involves X-ray-induced sublethal damage,
the repair of which normally completes
approximately 3 h after X-irradiation.
Similarly, the combinedeffect ofbleomycin
administered before X-rays may be also
related to repair of bleomycin-induced
damage (Fig. 3). The fact that both agents
induce reparable damage of cellular DNA
(Tsuboi and Terasima, 1970; Terasima,
Yasukawa and Umezawa, 1970; Fujiwara
and Kondo, 1973; Saito and Andoh, 1973)
maybe a basis for part of the potentiation.
The observed interaction between dam-
ages due to X-ray and bleomycin may
provide practicable means to control
repair. Using transplantable mouse tu-
mour, J0rgensen (1972) demonstrated that
simultaneous administration resulted in
greater reduction in tumour weight than
alternating administration. The result
may be understood on the basis of the
damage-interaction hypothesis suggested
here.
The present study was supported by
a grant from the Japanese Ministry of
Education under the auspices of Prof. M.
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